These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 8858387)
1. Nicotinamide: potential for the prevention of type 1 diabetes? Gale EA Horm Metab Res; 1996 Jul; 28(7):361-4. PubMed ID: 8858387 [No Abstract] [Full Text] [Related]
2. [Pre-diabetes type 1. Evaluation of current clinical trials]. Thivolet C Journ Annu Diabetol Hotel Dieu; 1997; ():201-5. PubMed ID: 9296975 [No Abstract] [Full Text] [Related]
3. [Use of alpha-tocopherol acetate and nicotinamide at the onset of insulin dependent diabetes mellitus]. Dedov II; Gorelysheva VA; Romanovskaia GA; Filippov IK; Smirnova OM Klin Med (Mosk); 1995; 73(6):40-3. PubMed ID: 8691780 [No Abstract] [Full Text] [Related]
4. Pilot trial to prevent type I diabetes: progression to overt IDDM despite oral nicotinamide. Herskowitz RD; Jackson RA; Soeldner JS; Eisenbarth GS J Autoimmun; 1989 Oct; 2(5):733-7. PubMed ID: 2529865 [No Abstract] [Full Text] [Related]
5. Clinical review 17: Immunotherapy of type I diabetes mellitus. Marks JB; Skyler JS J Clin Endocrinol Metab; 1991 Jan; 72(1):3-9. PubMed ID: 1986025 [No Abstract] [Full Text] [Related]
6. Immune intervention with anti-CD3 in diabetes. Harlan DM; von Herrath M Nat Med; 2005 Jul; 11(7):716-8. PubMed ID: 16015359 [No Abstract] [Full Text] [Related]
7. Identification of insulin-dependent diabetes mellitus before the onset of clinical symptoms. Riley WJ; Winter WE; Maclaren NK J Pediatr; 1988 Feb; 112(2):314-6. PubMed ID: 3276866 [No Abstract] [Full Text] [Related]
8. [Current therapeutic strategy in type 1 diabetes and its preclinical stages]. Martin S; Kolb H; Lampeter EF Internist (Berl); 1996 Dec; 37(12):1289-304. PubMed ID: 9081933 [No Abstract] [Full Text] [Related]
9. [Predicting the development of diabetes mellitus type 1]. Jaskóła K; Bernaś M; Luźniak P; Szczeklik Z; Tatoń J Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):40-2. PubMed ID: 1409041 [No Abstract] [Full Text] [Related]
10. Strategies for preventing type I diabetes mellitus. Verge CF; Eisenbarth GS West J Med; 1996 Mar; 164(3):249-55. PubMed ID: 8775937 [TBL] [Abstract][Full Text] [Related]
11. [Early diagnosis of type-1 diabetes. Limits, possibilities and outlook]. Kuglin B; Bertrams J; Kolb H; Gries FA Dtsch Med Wochenschr; 1989 May; 114(19):762-7. PubMed ID: 2653770 [No Abstract] [Full Text] [Related]
15. Molecular mechanisms of beta-cell destruction in IDDM: the role of nicotinamide. Gale EA Horm Res; 1996; 45 Suppl 1():39-43. PubMed ID: 8805029 [TBL] [Abstract][Full Text] [Related]
16. Prediabetes: prediction and prevention trials. Vendrame F; Gottlieb PA Endocrinol Metab Clin North Am; 2004 Mar; 33(1):75-92, ix. PubMed ID: 15053896 [No Abstract] [Full Text] [Related]
17. Effects of nicotinamide on prevention and treatment of streptozotocin-induced diabetes mellitus in rats. Hu Y; Wang Y; Wang L; Zhang H; Zhang H; Zhao B; Zhang A; Li Y Chin Med J (Engl); 1996 Nov; 109(11):819-22. PubMed ID: 9275363 [TBL] [Abstract][Full Text] [Related]
19. Nicotinamide trials in diabetes intervention. Does a metabolite provide benefit? Gosteli J Med Hypotheses; 2005; 64(5):1062-3. PubMed ID: 15780513 [No Abstract] [Full Text] [Related]